Map the CTD story before filing
Organize a regulatory filing narrative using CTD modules and identify cross-module inconsistencies.
A filing-readiness review shows each function is nearly complete, but the product, dose, and formulation story may not line up across modules. CTD coherence: Module 3 quality, Module 4 nonclinical, Module 5 clinical, reconciled in Module 2 The common trap is module completion without cross-module agreement. Step 1 List the product claim: dose, route, formulation, strength, patient population, and proposed use. This is the thread that must run through the filing. Step 2 Check Module 3 against the claim: specifications, process, stability, comparability, and commercial formulation. Quality evidence must describe the product that will actually be supplied. Step 3 Check…
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in